Aclaris Therapeutics Inc. (ACRS) Statistics & Valuation Metrics - Stocknear

Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
2.10
0.03 (1.45%)
At close: Sep 05, 2025, 3:59 PM
2.10
0.00%
After-hours: Sep 05, 2025, 05:24 PM EDT

Aclaris Therapeutics Statistics

Share Statistics

Aclaris Therapeutics has 108.33M shares outstanding. The number of shares has increased by 51.77% in one year.

108.33M
51.77%
0.34%
69.8%
92.29M
1,557
0.14%

Short Selling Information

The latest short interest is 5.98M, so 5.52% of the outstanding shares have been sold short.

5.98M
5.52%
6.58%
6.9

Valuation Ratios

The PE ratio is -1.45 and the forward PE ratio is -3.91. Aclaris Therapeutics's PEG ratio is -0.04.

-1.45
-3.91
10.24
41.5
1.23
-9.49
-0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Aclaris Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.02.

3.99
3.99
0.02
-0.05
-0.13
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$306.89K
$-2.17M
61
0.08
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 79.49% in the last 52 weeks. The beta is 0.29, so Aclaris Therapeutics's price volatility has been higher than the market average.

0.29
79.49%
1.66
1.98
79.39
1,120,324

Income Statement

In the last 12 months, Aclaris Therapeutics had revenue of 18.72M and earned -132.06M in profits. Earnings per share was -1.71.

18.72M
15.93M
-141.93M
-132.06M
-51.72M
-52.53M
-1.71
Full Income Statement

Balance Sheet

The company has 24.57M in cash and 2.6M in debt, giving a net cash position of 21.97M.

24.57M
2.6M
21.97M
-902.86M
189.15M
77.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.07M and capital expenditures -121K, giving a free cash flow of -20.2M.

-20.07M
-121K
-20.2M
-0.26
Full Cash Flow Statement

Margins

Gross margin is 85.09%, with operating and profit margins of -758.18% and -705.48%.

85.09%
-758.18%
-705.48%
-705.48%
-276.28%
-758.18%
-107.88%

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ACRS is $7.5, which is 257.1% higher than the current price. The consensus rating is "Buy".

$7.5
257.1%
Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.98
2